Pneumococcal Infections
📧 Sign up to get email alerts when something new happens for Pneumococcal Infections.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2017-11-24EMA Withdrawn: Prevenar (pneumococcal oligosaccharide serotype 18C;Pneumococcal polysaccharide serotype 19F;Pneumococcal polysaccharide serotype 23F;Pneumococcal polysaccharide serotype 4;Pneumococcal polysaccharide serotype 6B;Pneumococcal polysaccharide serotype 9V;Pneumococcal polysaccharide serotype 14) — Pfizer Limited
European Medicines Agency withdrew Prevenar from the market (pneumococcal serotypes) handled by Pfizer Limited.
-
CLINICAL_TRIALS withdrawal · 2017-01-10Clinical Trial Update: Antibodies and Memory Cells Role After Different Pneumococcal Vaccines in HIV Adults
This clinical trial evaluating antibodies and memory cells after different pneumococcal vaccines in adults with HIV was withdrawn, with no r…
-
CLINICAL_TRIALS withdrawal · 2013-09-09Clinical Trial Update: Post-marketing Safety Study of GlaxoSmithKline (GSK) Biologicals' Synflorix™ Vaccine, in Healthy Infants and Children in Sri Lanka
A post-marketing safety study of GlaxoSmithKline's Synflorix pneumococcal vaccine in healthy infants and children in Sri Lanka has been with…